Edap Tms S.A. (NASDAQ:EDAP) Sees Large Decrease in Short Interest

Edap Tms S.A. (NASDAQ:EDAP) was the target of a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 75,567 shares, a drop of 20.6% from the January 15th total of 95,120 shares. Based on an average daily trading volume, of 82,208 shares, the short-interest ratio is presently 0.9 days. Approximately 0.2% of the company’s stock are short sold. Approximately 0.2% of the company’s stock are short sold. Based on an average daily trading volume, of 82,208 shares, the short-interest ratio is presently 0.9 days.

Edap Tms Stock Down 1.2%

NASDAQ EDAP traded down $0.05 during mid-day trading on Tuesday, reaching $4.62. The stock had a trading volume of 13,077 shares, compared to its average volume of 87,581. The stock has a market cap of $172.59 million, a PE ratio of -8.10 and a beta of -0.16. Edap Tms has a 1 year low of $1.21 and a 1 year high of $5.05. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.41 and a quick ratio of 0.97. The company has a fifty day moving average price of $3.70 and a 200 day moving average price of $2.67.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. Wall Street Zen raised shares of Edap Tms to a “hold” rating in a research report on Saturday, February 7th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $2.00 price objective on shares of Edap Tms in a research note on Thursday, November 6th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $8.50.

Institutional Investors Weigh In On Edap Tms

Institutional investors have recently modified their holdings of the business. Financial Planning Navigators CORP purchased a new stake in shares of Edap Tms during the 4th quarter valued at about $33,000. Kovack Advisors Inc. bought a new position in Edap Tms during the fourth quarter valued at approximately $53,000. Leonteq Securities AG bought a new position in Edap Tms during the fourth quarter valued at approximately $313,000. Finally, Sage Mountain Advisors LLC purchased a new stake in Edap Tms in the second quarter worth approximately $165,000. 62.74% of the stock is owned by hedge funds and other institutional investors.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.